Realtime | Geld | Brief | Zeit |
---|---|---|---|
15,900 | 16,150 | 15.08. | |
15,900 | 16,150 | 15.08. |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
24.07. | Pihlajalinna Oyj: Pihlajalinna Half Year Financial Report 1 January-30 June 2025: Continued improvement in Pihlajalinna's profitability | 66 | GlobeNewswire (Europe) | Pihlajalinna Plc Half Year Financial Report 24 July 2025 at 8:00 a.m. EET
Pihlajalinna Half Year Financial Report 1 January-30 June 2025
Continued improvement in Pihlajalinna's profitability
This... ► Artikel lesen | |
18.06. | PIHLAJALINNA OYJ: Pihlajalinna starts repurchasing own shares | 2 | Cision News | ||
30.05. | Pihlajalinna Oyj: Inside information, profit warning: Pihlajalinna updates its guidance for 2025 | 206 | GlobeNewswire (Europe) | Pihlajalinna Plc Inside Information 30 May 2025 at 11:00 a.m.
Inside information, profit warning: Pihlajalinna updates its guidance for 2025
Pihlajalinna... ► Artikel lesen | |
06.05. | PIHLAJALINNA OYJ: Transfer of Pihlajalinna's own shares | 1 | Cision News | ||
30.04. | Pihlajalinna Oyj: Pihlajalinna's medium-term strategic targets | 162 | GlobeNewswire (Europe) | Pihlajalinna Plc Stock Exchange Release 30 April 2025 at 8:30 a.m.
Pihlajalinna's medium-term strategic targets
Pihlajalinna Plc's Board of Directors has approved the company's medium-term... ► Artikel lesen | |
30.04. | Pihlajalinna Oyj: Pihlajalinna Interim Report 1 January-31 March 2025: Pihlajalinna's profitability improved, steady revenue growth in Private Healthcare Services continued | 149 | GlobeNewswire (Europe) | Pihlajalinna Plc Interim Report 30 April 2025 at 8:00 a.m.
Pihlajalinna Interim Report 1 January-31 March 2025
Pihlajalinna's profitability improved... ► Artikel lesen | |
25.04. | Dividendenbekanntmachungen (25.04.2025) | 15.606 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABG SUNDAL COLLIER HOLDING ASA NO0003021909 0,5 NOK 0,0422 EUR ABN AMRO BANK NV NL0011540547 - 0,75 EUR ABSA GROUP LIMITED ADR US00400T1025 0... ► Artikel lesen | |
PIHLAJALINNA Aktie jetzt für 0€ handeln | |||||
24.04. | Pihlajalinna Oyj: Resolutions of the Annual General Meeting and the constitutive meeting of the Board of Directors of Pihlajalinna Plc | 209 | GlobeNewswire (Europe) | Pihlajalinna Plc Stock Exchange Release 24 April 2025 at 2:00 p.m.
Resolutions of the Annual General Meeting and the constitutive meeting of the Board of Directors... ► Artikel lesen | |
16.04. | PIHLAJALINNA OYJ: Pihlajalinna Plc publishes Intermin Report for January 1-March 31, 2025, on Wednesday, 30 April 2025 | 1 | Cision News | ||
01.04. | PIHLAJALINNA OYJ: Pihlajalinna has published the 2024 Annual Report | 1 | Cision News | ||
25.03. | PIHLAJALINNA OYJ: Invitation to Pihlajalinna's Capital Markets Day on 9 May 2025 | 1 | Cision News | ||
19.03. | PIHLAJALINNA OYJ: Pihlajalinna Plc: Notice to Annual General Meeting | 1 | Cision News | ||
14.03. | PIHLAJALINNA OYJ: Pihlajalinna's disposal of own shares based on the share-based incentive programme | 2 | Cision News | ||
12.02. | Pihlajalinna Oyj: Pihlajalinna Financial Statements Release 1 January-31 December 2024: Strong organic growth, operating cash flow and profitability development in 2024 | 135 | GlobeNewswire (Europe) | Pihlajalinna Plc Financial Statements Release 12 February 2025 at 8:00 a.m.
Pihlajalinna Financial Statements Release 1 January-31 December 2024
Strong organic growth, operating cash flow... ► Artikel lesen | |
07.11.24 | Pihlajalinna Oyj: Pihlajalinna Interim Report 1 January-30 September 2024: Solid development in organic growth and profitability | 128 | GlobeNewswire (Europe) | Pihlajalinna Plc Interim Report 7 November 2024 at 8:00 a.m.
Pihlajalinna Interim Report 1 January-30 September 2024
Solid development in organic... ► Artikel lesen | |
30.10.24 | Pihlajalinna Oyj: Insider information, positive profit warning: Pihlajalinna upgrades its profitability guidance for 2024 and provides preliminary information on revenue and profitability for the third quarter of 2024 | 158 | GlobeNewswire (Europe) | Pihlajalinna Plc Insider Information 30 October 2024 at 8:00 a.m.
Insider information, positive profit warning: Pihlajalinna upgrades its profitability guidance... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
BICO GROUP | 3,160 | 0,00 % | Schock-News für Bico Group Anleger vor dem Wochenende: So müssen Sie heute noch auf diese Sondermeldung reagieren! | ||
EUROFINS SCIENTIFIC | 67,92 | +0,27 % | Eurofins Sustainability Services Introduces Origin ID for Cotton Traceability - Offering Unparalleled Expertise and Support for Cotton Supply Chains | Eurofins Sustainability Services, a full-service provider for retailers, brands, and manufacturers of consumer products, has grown its extensive service offering to include Origin ID, a leading... ► Artikel lesen | |
PING AN HEALTHCARE | 1,690 | +0,36 % | HSI Closes Midday at 24,929, Up 22 pts; HSTI Closes Midday at 5,438, Down 21 pts; KUAISHOU-W Down over 6%; CH MODERN D, BRILLIANCE CHI, YOURAN DAIRY, PA GOODDOCTOR, REALORD GROUP Hit New Highs | ||
EMEIS | 13,830 | -1,14 % | emeis: Sales and Business Update at the End of June 20251 | Sustained growth in operating margins
Sustained revenue growth
+6.2% on a like-for-like basis
Net operational recovery
EBITDAR up nearly +20% on a like-for-like basis
EBITDA (excluding... ► Artikel lesen | |
CYTOSORBENTS | 0,954 | +6,95 % | Cytosorbents outlines DrugSorb ATR regulatory appeals and targets core business breakeven as German reorganization drives 22% sales growth | ||
CLARIANE | 4,640 | +0,13 % | Korian Stiftungsaward 2025 geht an vielfältig. GmbH Bremen - erster ambulanter Pflegedienst mit Fokus auf Sexualität und Vielfalt | München (ots) - Der diesjährige Korian Stiftungsaward für Vielfalt und Respekt in der Pflege der Korian Stiftung für Pflege und würdevolles Altern, geht an vielfältig. Bremen. Der ambulante Pflegedienst... ► Artikel lesen | |
ARJO | 2,944 | +0,07 % | Arjo AB: Andréas Elgaard appointed new President and CEO of Arjo | Arjo's Board of Directors has appointed Andréas Elgaard new President and CEO of the Group. Andréas most recently comes from the position as President and CEO of the publicly listed ITAB Shop Concept... ► Artikel lesen | |
ICON | 151,55 | +0,83 % | ICON suspends COVID vaccine study after BARDA notice | ||
M3 INC | 13,200 | +0,76 % | Deutliches Plus erfreut Inhaber der M3-Aktie (12,50 €) | Grund zur Freude haben Aktionäre von M3 : Das Papier steigt deutlich. Zu den stärksten Werten des Tages gehört heute der Anteilsschein von M3 mit einem Wertanstieg von 11,61 Prozent. Für das Papier... ► Artikel lesen | |
DYNAVOX GROUP | 11,100 | +0,91 % | Dynavox Group AB: Dynavox Group Interim Report second quarter 2025 | Dynavox Group AB (publ) today announced its results for the second quarter 2025.
Comment from the Dynavox Group CEO Fredrik Ruben:
Dynavox Group delivered another quarter of exceptional growth and... ► Artikel lesen | |
NYXOAH | 5,600 | +3,13 % | EQS-News: Nyxoah SA.: Nyxoah gibt vorläufige Finanzergebnisse für das zweite Quartal 2025 bekannt | EQS-News: Nyxoah SA.
/ Schlagwort(e): Sonstiges
Nyxoah gibt vorläufige Finanzergebnisse für das zweite Quartal 2025 bekannt
11.08.2025 / 07:00 CET/CEST
Für den Inhalt... ► Artikel lesen | |
INTERPACE BIOSCIENCES | 0,740 | -0,67 % | INTERPACE BIOSCIENCES, INC. - 8-K, Current Report | ||
CHINA MEDICAL SYSTEM | 1,460 | -0,68 % | China Medical System Holdings Limited: CMS Collaborates with SGX to Explore New Paradigms for Industrial Globalization and Pharmaceutical Expansion Overseas across Emerging Markets | SINGAPORE, July 21, 2025 - (ACN Newswire) - On July 15 2025, to mark the successful secondary listing of China Medical System Holdings Limited ("CMS" or the "Group") on the Main Board of the Singapore... ► Artikel lesen | |
NANOSONICS | 2,160 | -0,92 % | NANOSONICS LIMITED: FY25 Full Year Results webinar notification | ||
VIVANI MEDICAL | 1,060 | -1,85 % | Vivani Medical, Inc.: Vivani Medical Provides Business Update Including $10M Equity Financing and Reports Second Quarter 2025 Financial Results | Company plans rapid advancement of semaglutide implant NPM-139, following positive weight loss data from an ongoing preclinical study of NPM-139 and promising results from the LIBERATE-1 Phase 1 clinical... ► Artikel lesen |